tradingkey.logo
tradingkey.logo
Search

LeMaitre Vascular Inc

LMAT
Add to Watchlist
98.740USD
+2.780+2.90%
Close 07/01, 16:00ETQuotes delayed by 15 min
2.25BMarket Cap
35.90P/E TTM

LeMaitre Vascular Inc

98.740
+2.780+2.90%
View Detailed Chart
TradingKey 图表
Intraday
1m
30m
1h
D
W
M
D

Today

+2.90%

5 Days

+7.38%

1 Month

+4.32%

6 Months

+21.75%

Year to Date

+21.75%

1 Year

+18.89%

Key Figures
96.560Open
99.735High
577.61KVolume
35.90P/E TTM
29.69P/E Dynamic
0.850Dividend TTM
2.54%Turnover Ratio
95.960Prev. Close
96.560Low
41.36MTurnover
51.06P/E Static
5.71P/B
0.86%Div Yield TTM
10.53%ROA
118.01052wk High
1.37Volume Ratio
44.04MNet Profit
22.77MShares
2.7501EPS TTM
0.55Beta
16.55%ROE
79.00552wk Low
3.31%Amplitude
72.72%Gross Margin
2.25BMarket Cap
2.66Reward/Risk
1.78%Risk Rate

Key Insights

LeMaitre Vascular Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 15 out of 204 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 118.75.In the medium term, the stock price is expected to trend down.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

LeMaitre Vascular Inc's Score

Industry at a Glance

Industry Ranking
15 / 204
Overall Ranking
55 / 4569
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

LeMaitre Vascular Inc Highlights

StrengthsRisks
LeMaitre Vascular, Inc. is a provider of devices, implants, and services for the treatment of peripheral vascular disease. The Company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and other specialties, such as cardiac surgeons, general surgeons, and neurosurgeons. Its portfolio of product lines is used to treat vascular disease, which used in open vascular surgery and dialysis access. It also offers human vascular and cardiac tissue cryopreservation services. Its principal product lines include anastomotic clips, biologic vascular and dialysis grafts, biologic vascular and cardiac patches, carotid shunts, embolectomy and occlusion catheters, radiopaque marking tape, synthetic vascular and dialysis grafts, and valvulotomes. Its principal biologic offerings include vascular and cardiac patches as well as vascular and dialysis grafts. Its product offerings are sold primarily in the United States, Europe, Canada, and Asia Pacific.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 29.00% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 249.60M.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 32.65%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 32.65%.
Undervalued
The company’s latest PE is 34.89, at a low 3-year percentile range.
Institutional Buying
The latest institutional holdings are 23.53M shares, increasing 3.50% quarter-over-quarter.
Held by HACAX
Star Investor HACAX holds 10.24K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.90.

Analyst Rating

Based on 9 analysts
Buy
Current Rating
118.750
Target Price
+23.75%
Upside Space

LeMaitre Vascular Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

LeMaitre Vascular Inc Info

LeMaitre Vascular, Inc. is a provider of devices, implants, and services for the treatment of peripheral vascular disease. The Company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and other specialties, such as cardiac surgeons, general surgeons, and neurosurgeons. Its portfolio of product lines is used to treat vascular disease, which used in open vascular surgery and dialysis access. It also offers human vascular and cardiac tissue cryopreservation services. Its principal product lines include anastomotic clips, biologic vascular and dialysis grafts, biologic vascular and cardiac patches, carotid shunts, embolectomy and occlusion catheters, radiopaque marking tape, synthetic vascular and dialysis grafts, and valvulotomes. Its principal biologic offerings include vascular and cardiac patches as well as vascular and dialysis grafts. Its product offerings are sold primarily in the United States, Europe, Canada, and Asia Pacific.
Ticker SymbolLMAT
CompanyLeMaitre Vascular Inc
CEOLemaitre (George W)
Websitehttps://www.lemaitre.com/

FAQs

What is the current price of LeMaitre Vascular Inc (LMAT)?

The current price of LeMaitre Vascular Inc (LMAT) is 95.96.

What is the symbol of LeMaitre Vascular Inc?

The ticker symbol of LeMaitre Vascular Inc is LMAT.

What is the 52-week high of LeMaitre Vascular Inc?

The 52-week high of LeMaitre Vascular Inc is 118.01.

What is the 52-week low of LeMaitre Vascular Inc?

The 52-week low of LeMaitre Vascular Inc is 79.00.

What is the market capitalization of LeMaitre Vascular Inc?

The market capitalization of LeMaitre Vascular Inc is 2.19B.

Is LeMaitre Vascular Inc (LMAT) currently rated as Buy, Hold, or Sell?

According to analysts, LeMaitre Vascular Inc (LMAT) has an overall rating of Buy, with a price target of 118.75.

What is the Earnings Per Share (EPS TTM) of LeMaitre Vascular Inc (LMAT)?

The Earnings Per Share (EPS TTM) of LeMaitre Vascular Inc (LMAT) is 2.55.